We offer a variety of grant opportunities to support education, charitable initiatives and fellowships. Our grant committe specializes in therapies related to neuromodulation medical devices. Please explore the options below to learn more and apply.
The medical device educational grant program from Abbott accepts requests for educational programs for healthcare professionals, patients, caregivers and the general public that cover neuromodulation therapy.
Apply for an educational grant
Frequently asked questions
Questions?
The medical device charitable grant program from Abbott accepts requests to support charitable programs and events serving low-income, indigent, underserved, and/or uninsured populations that relate to therapy areas associated with neuromodulation.
Apply for a charitable grant
Frequently asked questions
Questions?
The medical device fellowship grant program from Abbott accepts requests between October 1 and March 1 each year for US-based fellowship programs that cover therapy areas associated with neuromodulation.
Apply for a fellowship grant
Frequently asked questions
Questions?
Abbott is required by federal and state transparency regulations to report most payments involving physicians (directly and indirectly). During the formal application process, you will be asked to certify that you will provide Abbott with any information or assurances it needs to satisfy such transparency obligations. Failure to do so may require you to return some or all of the grant funds awarded by Abbott and will make you ineligible to receive funding in the future. Further detail will be provided on the information and/or assurances you will be required to provide. Your compliance is required, and Abbott cannot make any exceptions.
Complying with anti-kickback laws, the AdvaMed Code of Ethics and the Physician Payments Sunshine Act is mandatory for our business and is in our customer’s best interest.
Abbott is certified to follow the AdvaMed Code of Ethics.
The Physician Payments Sunshine Act is a federal law that requires healthcare manufacturers to track and report payments and transfers of value (POTV) to certain healthcare professionals (HCPs) and healthcare organizations (HCOs). Congress passed the Sunshine Act in 2010 in the interest of providing greater transparency into interactions between the healthcare industry and healthcare providers. Abbott supports the goals of the Sunshine Act because we recognize that transparency inspires public trust and confidence. Learn more about the sunshine act.
MAT-2676759 v1.0 | Item approved for U.S. use only.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
© 2026 Abbott. All Rights Reserved.
MAT-2623622 v14.0 | Item approved for U.S. use only.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.
26-00274 MAT-2214515 v2.0 | Item approved for U.S. use only.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
26-00270 MAT-2214513 v2.0 | Item approved for U.S. use only.
Chronic Pain